Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia
Status:
RECRUITING
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
To assess the 1-week effects and safety of esketamine in combination with pregabalin and duloxetine to relieve pain in patients with postherpetic Neuralgia(PHN).
Phase:
NA
Details
Lead Sponsor:
Beijing Tiantan Hospital
Collaborators:
Beijing Ditan Hospital Beijing Xiaotangshan Hospital Hengshui People's Hospital The First Hospital of Fangshan District,Beijing